After 6 months of the Phase 2 trial commencement-
Out of a cohort 1 of 17 patients: We have
7 patients achieved a positive response of tumours reduction, additional 6 patients see diseases stabilised. The overall 76% of disease control rate after 6 months (13/17patients) is a very positive sign..
Ann: Immutep expands Part A of TACTI-002 due to positive data, page-10
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $443.6M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 31.8¢ | 30.3¢ | $1.189M | 3.864M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 78803 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 1155 | 1 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |